COMP <GO>

CGC vs USNA // 10Y YIELD & FRED MACRO BETA

Canopy Growth Corporation (NASDAQ) VS. USANA Health Sciences Inc. (NYSE) • 15-METRIC TALLY: CGC 1 — USNA 2

■ METRIC PARITY

LAST: $0.65 (-3.33%) • MKT CAP: $285.6M

macro-sensitivity

—

LAST: $14.31 (-0.21%) • MKT CAP: $265.0M

macro-sensitivity

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CGC VS. USNA) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CGC	USNA	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	78.30%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	—	7.90%	—	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	2.7x	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	3.22%	—	TIE	/fcf-yield <GO>
Operating Margin	—	4.00%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	1.20%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	8.30%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	3.56	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	1/9	7/9	-6.00	USNA	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	33.6	45.8	-12.20	USNA	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	22.9x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$285.6M	$265.0M	$20.6M	CGC	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CGC REV	USNA REV	CGC GROSS %	USNA GROSS %	CGC FCF	USNA FCF
FY 2025	$0	$925.3M	—	78.3%	—	$8.5M
FY 2024	$0	$854.5M	—	81.1%	—	$50.9M
FY 2023	$0	$921.0M	—	—	—	$70.6M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CGC // BETA —

USNA // BETA —